Status:
UNKNOWN
The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision
Lead Sponsor:
Vrije Universiteit Brussel
Conditions:
Pterygium
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
In pterygium excision procedures, the subconjunctival injection of xylocain is regarded as an uncomfortable and painful step in the procedure. While already being studied in other ophthalmic procedure...
Detailed Description
Pterygia are known as fibrovascular degenerations in the outer layer of the eye. Usually, they cross the limbus onto the cornea. they develop over time and can cause symptoms such as redness, itching,...
Eligibility Criteria
Inclusion
- Indication of pterygium excision
Exclusion
- No history of auto-immune diseases such as Sjögren, Lupus, Graves, Graft-versus-host disease, rheumatoid artritis
- No history of deafness, anxiety disorders, communicative barrier, impossibility to comprehend the Visual Analogue Pain Scale or the OSDI questionnaire.
- Patient who already had pterygium excision
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05978687
Start Date
September 1 2023
End Date
December 31 2024
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Brussels, Brussels Capital, Belgium, 1090